Top Tweets for #APCCC2024
#Apccc2024 Gran experiencia!
An Amazing DAY2⃣of #APCCC24
Grateful to @APCCC_Lugano @Silke_Gillessen
@AOmlin and Team🇨🇭 for the AMAZING efforts that led to this GREAT meeting in #ProstateCancer
✅2⃣1⃣MILLION Impressions
✅OVER 3⃣.3⃣K Tweets
✅OncoAlert Faculty 1⃣4⃣.5⃣ million impressions
@nataliagandur @DrYukselUrun @mskamat
@RodRogSan @haroldss1 @tomassoule
@LoebStacy @urotoday @imedverse
@crisbergerot @VJOncology @Soum_Roy_RadOnc
@_sarahweller @Prof_IanD
@PBlanchardMD @PignotG @RodRogSan
@GGrisay @cristian_udo @ZEROProstateCEO
@DrSpratticus @yekeduz_emre
#OncoAlertAF
@acampsmalea @MartaPerachino @heinrich_kat
@BiagioRicciutMD @DenizCanGuven1
@HHorinouchi @FadiHaddad_MD @Dr_Ivanoncologo
@Abdallah81MD @FernandoOnco @ElisaAgostinett
@dr_yakupergun @to_be_elizabeth @CParkMD
While #APCCC2024 discussions are truly world class, Lugano is beautiful, the people are amazing…I have found a hidden gem they put all over the grocery store…these chocolate shakes are in Switzerland for crazy cheap they are amazing. Bring them to the 🇺🇸
Es fundamental testear a nuestros pacientes con cancer de prostata, cuanto antes mejor. Si bien en mHSPC aun no nos modifica la conducta en 1ra linea (fuera de ensayos clínicos), si es determinante para definir la 1ra linea de mCRPC. #APCCC2024 #prostatecancer @OncoAlert
@APCCC_Lugano #APCCC2024 important consensus in metastasic disease performing germline and somatic testing, not so clear in localized high risk @urotoday @UroTarget @OncoAlert @achoHematoYOnco @SCUColombia @Silke_Gillessen @AOmlin 🦾🦾🦾
@APCCC_Lugano #APCCC2024 neuroendocrine prostate cancer have a worse prognosis, and limited evidence in management. However promising options of treatment could be used, waiting for more data. @urotoday @UroTarget @OncoAlert @achoHematoYOnco @SCUColombia @AarmstrongDuke 🦾🦾🦾
Patients need to be educated to ask about genetic testing. It is not offered nearly enough in clinics. Even in early stage, it not only has prognostic value- it has value to the families of the patient. #patientadvocacy #APCCC2024
@APCCC_Lugano #APCCC2024 outstanding review by @mishabeltran losses in tumor suppressions related with aggressive variant prostate cancer issue, with dediferentiated disease expressing in mCRPC @urotoday @UroTarget @achoHematoYOnco @SCUColombia 🦾🦾🦾
Still the best definition of agressive variant prostate cancer so far #APCCC2024 @mishabeltran @aaparicioMD
@APCCC_Lugano #APCCC2024 Non DDR alterations have an important role as prognostic factor, important to start migrate as a predictive tools. @urotoday @UroTarget @OncoAlert @achoHematoYOnco @SCUColombia @aaparicioMD 🦾🦾🦾
#APCCC2024 Why is germline genetic testing important?
@APCCC_Lugano #APCCC2024 important summary in prevalence germline mutation in prostate cancer. Important to sensitize every actor in prostate cancer of this important issue @urotoday @UroTarget @achoHematoYOnco @SCUColombia
Wow that’s amazing slide!
How to Choose the best option in mCRPC after triplet therapy in the mHSPC setting. Practical guidance
#APCCC2024 #ProstateCancer
Prof Vedang Murthy. Brilliant.
#APCCC2024
Spectacular results of progression-directed therapy in oligoprogressive CRPC. Congrats to team #APCCC2024 #prostatecancer #SBRT #prospective @joniau @AlbertoBossial @KatoRans
Proud to present the final results of the MEDCARE phase II study published in @EurUrolOncol!
Progression-directed Therapy in Oligoprogressive Castration-resistant Prostate Cancer! ⚡️
@GertMeerleer @joniau @karolien_goffin @CharlienBerghen @Haustermans
https://t.co/cOQWePYr1n
En pacientes progresados a ADT+Docetaxel+ARPI, la mayoría de los panelistas optaron por Lu-PSMA como linea subsecuente. La teragnosis vino para quedarse!
#APCCC2024 @APCCC_Lugano @UroTeragLATAM
Inequality is real when patients don’t have resources to get a diagnosis even. Spotlight on disparities in cancer care by @VedangMurthy at #APCCC2024. But, how do we deal in community and private practice?
@VedangMurthy at #APCCC24 for #prostatecancer!
Inequalities are everywhere, what are we going to do about it?
@TataMemorial 🇮🇳showing the way with many innovative solutions!
@APCCC_Lugano @urosogo @RadOncTMC @ACTREC_TMC
APCCC debate with Thomas Zilli and Pierre Blanchard covering radiation therapy for metastatic disease from Lugano. Thanks to @neerajaiims for help with the tweet. #APCCC2024 @OncoAlert . https://t.co/tZFKgt0VTs
Excelente presentacion de Karim Fizazi en #APCCC2024, panel de lujo. Secuenciando tratamientos en cancer de prostata metastasico.
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.9M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers